位置:首页 > 蛋白库 > DMXL2_CRYX8
DMXL2_CRYX8
ID   DMXL2_CRYX8             Reviewed;        2406 AA.
AC   A0A4P8DJV2;
DT   29-SEP-2021, integrated into UniProtKB/Swiss-Prot.
DT   31-JUL-2019, sequence version 1.
DT   03-AUG-2022, entry version 13.
DE   RecName: Full=Highly reducing polyketide synthase dmxL2 {ECO:0000303|PubMed:30996871};
DE            EC=2.3.1.- {ECO:0000305|PubMed:30996871};
DE   AltName: Full=Dimeric xanthone biosynthesis cluster protein L2 {ECO:0000303|PubMed:30996871};
GN   Name=dmxL2 {ECO:0000303|PubMed:30996871};
OS   Cryptosporiopsis sp. (strain 8999).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Leotiomycetes;
OC   Helotiales; Dermateaceae; Cryptosporiopsis; unclassified Cryptosporiopsis.
OX   NCBI_TaxID=2572248;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   PATHWAY.
RC   STRAIN=8999;
RX   PubMed=30996871; DOI=10.1039/c8sc05126g;
RA   Greco C., de Mattos-Shipley K., Bailey A.M., Mulholland N.P., Vincent J.L.,
RA   Willis C.L., Cox R.J., Simpson T.J.;
RT   "Structure revision of cryptosporioptides and determination of the genetic
RT   basis for dimeric xanthone biosynthesis in fungi.";
RL   Chem. Sci. 10:2930-2939(2019).
CC   -!- FUNCTION: Highly reducing polyketide synthase; part of the gene cluster
CC       that mediates the biosynthesis of the dimeric xanthones
CC       cryptosporioptides (PubMed:30996871). The pathway begins with the
CC       synthesis of atrochrysone thioester by the polyketide synthase dmx-
CC       nrPKS (Probable). The atrochrysone carboxyl ACP thioesterase dmxR1 then
CC       breaks the thioester bond and releases the atrochrysone carboxylic acid
CC       from dmx-nrPKS (Probable). Atrochrysone carboxylic acid is
CC       decarboxylated by the decarboxylase dmxR15, and oxidized by the
CC       anthrone oxygenase dmxR16 to yield emodin (Probable). Emodin is then
CC       reduced to emodin hydroquinone by the oxidoreductase dmxR7 (Probable).
CC       A-ring reduction by the short chain dehydrogenase dmxR18, dehydration
CC       by the scytalone dehydratase-like protein dmxR17 and probable
CC       spontaneous re-oxidation, results in overall deoxygenation to
CC       chrysophanol (PubMed:30996871). Baeyer-Villiger oxidation by the
CC       Baeyer-Villiger monooxygenase (BVMO) dmxR6 then yields monodictylactone
CC       in equilibrium with monodictyphenone (PubMed:30996871). In the case of
CC       the cryptosporioptides biosynthesis, monodictylactone is reduced at C-
CC       12 to an alcohol (by the short chain dehydrogenases dmxR12 or dmxR8)
CC       and hydroxylated at C-5 by dmxR9, yielding the electron-rich aromatic
CC       which could eliminate H(2)O to form the ortho-quinonemethide, followed
CC       by tautomerisation to paraquinone and complete the formal reduction to
CC       produce the 10-methylgroup (Probable). Conjugate addition of C-4a-OH to
CC       the resulting paraquinone by the monooxygenase dmxR10 then gives
CC       cyclohexadienone, which is then reduced at C-5 by the short chain
CC       dehydrogenase dmxR3 to give the dihydroxanthone (Probable). The 6,7-
CC       epoxide in the cryptosporioptides could be introduced by the cytochrome
CC       P450 monooxygenase dmxL3 (Probable). The highly reducing PKS dmxL2
CC       manufactures butyrate, which is further carboxylated by dmxL1 to form
CC       ethylmalonate (PubMed:30996871). It is not yet clear whether the
CC       carboxylation occurs while the butyrate is attached to the ACP of
CC       dmxL2, but this unusual fungal metabolite could then be esterified to
CC       O-5 by the O-acetyltransferase dmxR13 (PubMed:30996871). Finally,
CC       dimerization performed by dmxR5 gives the observed dimers
CC       cryptosporioptides A, B and C as the final products of the pathway
CC       (PubMed:30996871). {ECO:0000269|PubMed:30996871,
CC       ECO:0000305|PubMed:30996871}.
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:30996871}.
CC   -!- DOMAIN: Multidomain protein; including a ketosynthase (KS) that
CC       catalyzes repeated decarboxylative condensation to elongate the
CC       polyketide backbone; a malonyl-CoA:ACP transacylase (MAT) that selects
CC       and transfers the extender unit malonyl-CoA; a dehydratase (DH) domain
CC       that reduces hydroxyl groups to enoyl groups; an enoyl reductase (ER)
CC       domain that reduces enoyl groups to alkyl group; a ketoreductase (KR)
CC       domain that catalyzes beta-ketoreduction steps; and an acyl-carrier
CC       protein (ACP) that serves as the tether of the growing and completed
CC       polyketide via its phosphopantetheinyl arm. {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Abolished production of cryptosprioptide B and C,
CC       and produces exclusively cryptosporioptide A.
CC       {ECO:0000269|PubMed:30996871}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MK182094; QCL09089.1; -; Genomic_DNA.
DR   SMR; A0A4P8DJV2; -.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 1.
DR   Gene3D; 3.10.129.110; -; 1.
DR   Gene3D; 3.40.366.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR013149; ADH-like_C.
DR   InterPro; IPR011032; GroES-like_sf.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR032821; PKS_assoc.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR020843; PKS_ER.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR002364; Quin_OxRdtase/zeta-crystal_CS.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 2.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF14765; PS-DH; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 1.
DR   SUPFAM; SSF47336; SSF47336; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 2.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR   PROSITE; PS50075; CARRIER; 1.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
DR   PROSITE; PS01162; QOR_ZETA_CRYSTAL; 1.
PE   3: Inferred from homology;
KW   Acyltransferase; Multifunctional enzyme; NADP; Oxidoreductase;
KW   Phosphopantetheine; Phosphoprotein; Transferase.
FT   CHAIN           1..2406
FT                   /note="Highly reducing polyketide synthase dmxL2"
FT                   /id="PRO_0000453498"
FT   DOMAIN          2318..2395
FT                   /note="Carrier"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          1..402
FT                   /note="Ketosynthase (KS) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          414..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          574..911
FT                   /note="Malonyl-CoA:ACP transacylase (MAT) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          964..1273
FT                   /note="Dehydratase (DH) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          1694..2006
FT                   /note="Enoylreductase (ER) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          2032..2210
FT                   /note="Ketoreductase (KR) domain"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        416..470
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        130
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        130
FT                   /note="For beta-ketoacyl synthase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        665
FT                   /note="For malonyltransferase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        994
FT                   /note="For beta-hydroxyacyl dehydratase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   MOD_RES         2355
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   2406 AA;  260448 MW;  F2F8725A5229E81A CRC64;
     MEAFWSASKK RSTSVAKGAH FLRQDISRFD ANFFGLPKHE ADAMDPQQRI MMEVAYEALE
     GAGLPLDQIA GSRTGVFVGH FSNDYRDMIC RDPDDAPLYS FTGTSTASLA NRLSYLWDLR
     GPSFSINTAC SSSLVALHLA CQSLQRGECE IAIVGGSNLL LNPEMFMFLS NQGFLSPDGK
     CKSFDESANG YGRGEGFGCV ILKRVDDAVL AGDAIRAVIR GTGSNQDGRT KGLTTPSAEA
     QRALIEEVYQ RAGLDFKTTG YTEAHGTGTQ AGDSQEMNAL AKTIAATHTA ESKLIVGSVK
     SNVSQSSAQN SCRFLTCLQI GHLEAAAGIA SVIKAVLMLE RGLIPPTIHF KKGNPKIPFD
     EWNIRVPTTL TPWPTDGVRR ISINSFGYSG TNAHAVLDDA YHYLEAKKHA FDKGHASNGT
     NGTLTNGHIL NGEHTSNGMN GTLTNGHASN DEHALNGTND ALTNGHGPTD GPTSRPRLFI
     WSAQDKDGLK RVREPLAQYI QAKAAEYQQD QSLKTEETFM SELAYTLSER RSRLQWKTYT
     IASSPSTLSA SLSLGEEASA TPVALSSRNP RIGFVFTGQG AQWPRMGAEL MAYPAFRECI
     EAAGSYLQGV CGCPWSAAEE LQKHKSISLV NSSAYSHALC TILQVALVDL LRTWGITPTA
     VVGHSGGEIA SAYAFGALTR EDAWRVAYHR GRLSAAIKTK APGLNGAMMA VALSPEQAAE
     WISKVTDGHL VVACINSPTS VTIAGDSLGI DQLLGMLQEK GGIFARKLLV DTAYHSPHMK
     IIADDYHAMI SDVMPRAAQG GCIMSSSVTG AVVEATQLGA DYWTASLTSP VRFSEAIYDM
     LRPIRGKTRL EENTVDVLVE VGPHSALQGP ATQSIKVHNI ANVPYYSVLR RNQDAVDTAL
     NLAGSLFTQG YKVDIRQVND DGDAHFAAPL TDLPTYSWNH SQRFWHESRM EREFRSRAAP
     KPSLLGSPSP SLAEGERIWR GFIRPAEAPW VNDHKIHGAV LYPGAGYLAM ALEAATQTAD
     TTRRVVAYKL RDIQLTAAAL VADGANLEYI VQLRPHVVGN RDSTAAWTEF IVTTAPDGKA
     LVQNCRGLLV IEYEAAEGSD TSRERSLELQ GWKTQYVDAQ QACVHRLDPS GFYSDMRSWG
     LDYGPAFANV CEVRNRDGQS VGSVRIPDIP APIVDGSDRP HVVHPGTLDA VFHLAFAAAK
     GGAYAPSTAM VPKSIDAITI AANVPFQAGT RLPGFSRAGR HGLNELVADI VMLDDTEHLP
     AIVIEGFLCA EIAGASSNSA DNSAKSLASR VTWRPALGLL SSDDLCSALS AHIGEAKLVE
     YLKLFHHSNP VLSVLEVAAV PNPQEPTPTP LLQRECLASV AKTWDVTTAC RDETLKTSMR
     QEAALEVLDF GQDLDTDVPE AYDLLIASDL SLYASDPVPA VERMCKVLKQ GGAICILTTD
     SIFLRIQPFL DACHMEVTVL PNPHGSDAAP SQDPSLIIAK KSLPYTNGIN GAAARPQQVT
     LIQAAHPTEA AIAMASQLTV SLEEHGYEAH VVSWGSDMST LAGKSCISLV EFQKTLLQDL
     AVDDFQSVKK LLLETGKLLW VTALDDPSAA MIDGLVRVVR NETPGLSLRV FHADEPTLAP
     AERLAGMLAK AFLWTGQDNE FRVQGNLLHV SRIEEDTTLN EEIHGLLPGA ARTISRIPLK
     DVQYPVKLCV QTPGMLGSVC LEPDDSAETV LGPDFIEIHV KATALNFREV MVAMGQMADS
     KLGIDAAGVV RRVGSSVTKF KVGDKVAMYG HGAHRTIHRS RADYCALIPD GMSFEEAATI
     PAVHGTAWNA LVRLARVQKG QSILIHAAAG GVGQVAVQIA RHTGMEIFAT VSSEAKRKLL
     RDEYGVPDDH IFNSRDLSFV KGVKRMTNGR GVDVVLNSLA GEALRQTWHC IAPFGYFVEI
     GVRDIINNTG LDMRPFMQDA TFSFFNLTHI EQDRPDIMGA IIQGAFDFLR RGITQLVTPM
     VTFPISDVEG ALRLMQTGKH LGKIALSWDE DHAEPISVVQ PRMRAPKLDP DGVYLLVGGL
     GGLGRSLSSK LVSLGARRLC FLSRSGARSA NAKDLIDKLE QQQVRVQIQT CDVADESAIA
     SAVDRCTREL GKIRGVFQCA MVLRDGLFAN MTHQQWVEST RPKVQGSWNL HQHLPDDLDF
     FITLSSFTAT FGSRGQSNYA AAGAYEDALA YHRRTRGRHA TTVDLGIMRD VGVLAETGMT
     DAFREWEKPY GIRESEFLVL MERVIDRDIA AIMPPQVLTG FATGGSVSSA GISTPYYMED
     ARFSILARTG VRDDGASAAS TDAVPAYTLV SQAKSFQEAS DSVLEALVRQ VAKMFQTPPS
     EIDTSRFLHS YGIDSLVAIE IVNWVMREAK STMTVFDVLA GVPMTTFCNR IAAKSTVLPK
     ELVPVH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024